大飛機板塊走強 航發科技(600391.SH)漲停
格隆匯2月27日丨大飛機板塊走強,航發科技漲停,航發控制、航發動力漲超5%,中航高科、新研股份、航天電子等跟漲。26日,東航旗下的一二三航空有限公司正式揭牌成立,未來將主要運營ARJ21、C919等國產飛機。去年8月,東航、國航、南航同時宣佈,分別與中國商飛簽署飛機購買合同,三家航空公司計劃各引進35架ARJ21-700飛機。國產大飛機C919目前也有6架試飛飛機正在開展不同科目的試飛,按照計劃,有望明年底前首架交付啟動用户東航。中航證券分析師張超認為,我國研製和發展大飛機,可以帶動新材料、發動機、電子信息、自動控制、計算機等領域關鍵技術的羣體突破,拉動眾多高技術產業發展,推動整個工業體系技術創新。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.